{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:16:26Z","timestamp":1792149386733,"version":"4.4.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,9,1]]},"DOI":"10.1093\/cid\/ciu398","type":"journal-article","created":{"date-parts":[[2014,5,27]],"date-time":"2014-05-27T23:32:22Z","timestamp":1401233542000},"page":"666-675","source":"Crossref","is-referenced-by-count":150,"title":["Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?"],"prefix":"10.1093","volume":"59","author":[{"given":"Thomas P.","family":"Lodise","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Drusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Zasowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Dihmess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lazariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Cosler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise-Anne","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,27]]},"reference":[{"key":"key\n\t\t\t\t20170522105039_CIU398C1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"key\n\t\t\t\t20170522105039_CIU398C3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0891-5520(03)00065-5","article-title":"Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid","volume":"17","year":"2003","journal-title":"Infect Dis Clin North Am"},{"key":"key\n\t\t\t\t20170522105039_CIU398C4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u2018bug and drug","volume":"2","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20170522105039_CIU398C5","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003088-200443130-00005","article-title":"Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections","volume":"43","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"suppl 1","key":"key\n\t\t\t\t20170522105039_CIU398C6","first-page":"S35","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"42","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C7","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1592\/phco.31.5.441","article-title":"Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg\/L suggested by the vancomycin consensus guidelines","volume":"31","year":"2011","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20170522105039_CIU398C8","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AAC.01485-12","article-title":"Vancomycin AUC\/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522105039_CIU398C9","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.1982.03330100028025","article-title":"Gentamicin dosing errors with four commonly used nomograms","volume":"248","year":"1982","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170522105039_CIU398C10","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/cir078","article-title":"Vancomycin: we can't get there from here","volume":"52","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C11","volume-title":"Performance standards for antimicrobial disk susceptibility tests; approved standards\u20149th ed","author":"Clinical and Laboratory Standards Institute","year":"2006"},{"key":"key\n\t\t\t\t20170522105039_CIU398C12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijantimicag.2013.10.017","article-title":"Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia","volume":"43","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170522105039_CIU398C13","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1128\/AAC.05609-11","article-title":"Vancomycin AUC24\/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522105039_CIU398C14","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1177\/0310057X1103900608","article-title":"Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients","volume":"39","year":"2011","journal-title":"Anaesth Intensive Care"},{"key":"key\n\t\t\t\t20170522105039_CIU398C15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14740330903413514","article-title":"Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections","volume":"9","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"key\n\t\t\t\t20170522105039_CIU398C16","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","year":"2006","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522105039_CIU398C17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1179\/joc.1997.9.6.420","article-title":"Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?","volume":"9","year":"1997","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170522105039_CIU398C18","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522105039_CIU398C19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/j.1875-9114.1995.tb04335.x","article-title":"Association of vancomycin serum concentrations with outcomes in patients with gram-positive bacteremia","volume":"15","year":"1995","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20170522105039_CIU398C20","volume-title":"ADAPT 5 User's guide: pharmacokinetic\/pharmacodynamic systems analysis software","year":"2009"},{"key":"key\n\t\t\t\t20170522105039_CIU398C21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/600884","article-title":"Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients","volume":"49","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1128\/AAC.01653-13","article-title":"Are vancomycin troughs adequate for optimal dosing?","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522105039_CIU398C23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0196-6553(88)90053-3","article-title":"CDC definitions for nosocomial infections, 1988","volume":"16","year":"1988","journal-title":"Am J Infect Control"},{"key":"key\n\t\t\t\t20170522105039_CIU398C24","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1086\/375057","article-title":"Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia","volume":"36","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","article-title":"Prediction of creatinine clearance from serum creatinine","volume":"16","year":"1976","journal-title":"Nephron"},{"key":"key\n\t\t\t\t20170522105039_CIU398C26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","year":"1985","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20170522105039_CIU398C27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/519283","article-title":"A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients","volume":"45","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1086\/313650","article-title":"Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia","volume":"30","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C29","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1001\/archinte.162.19.2229","article-title":"Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus","volume":"162","year":"2002","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522105039_CIU398C30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C31","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard\u20149th ed","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"key\n\t\t\t\t20170522105039_CIU398C32","article-title":"Tests to assess bactericidal activity","volume-title":"Clinical microbiology procedures handbook","year":"2004"},{"key":"key\n\t\t\t\t20170522105039_CIU398C33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JCM.01508-06","article-title":"A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides","volume":"45","year":"2007","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170522105039_CIU398C34","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1128\/AAC.46.5.1492-1502.2002","article-title":"Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin","volume":"46","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170522105039_CIU398C35","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00007691-198907000-00013","article-title":"Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models","volume":"11","year":"1989","journal-title":"Ther Drug Monit"},{"key":"key\n\t\t\t\t20170522105039_CIU398C36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00007691-198905000-00009","article-title":"Evaluation of a two-compartment Bayesian forecasting program for predicting vancomycin concentrations","volume":"11","year":"1989","journal-title":"Ther Drug Monit"},{"key":"key\n\t\t\t\t20170522105039_CIU398C37","article-title":"Vancomycin dose recommendations for hospital-, ventilator- or health care-associated pneumonia and the attainment of vancomycin trough concentrations of 15-20 mg\/L: cognitive dissonance"},{"key":"key\n\t\t\t\t20170522105039_CIU398C38","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/529190","article-title":"Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522105039_CIU398C39","volume-title":"Recursive partitioning in the health sciences","year":"1999"},{"key":"key\n\t\t\t\t20170522105039_CIU398C40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/aje\/kwg074","article-title":"Estimating the relative risk in cohort studies and clinical trials of common outcomes","volume":"157","year":"2003","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170522105039_CIU398C41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/aje\/kwi188","article-title":"Easy SAS calculations for risk or prevalence ratios and differences","volume":"162","year":"2005","journal-title":"Am J Epidemiol"},{"key":"key\n\t\t\t\t20170522105039_CIU398C42","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","year":"2003","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20170522105039_CIU398C43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40262-012-0020-y","article-title":"Benchmarking therapeutic drug monitoring software: a review of available computer tools","volume":"52","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"key\n\t\t\t\t20170522105039_CIU398C44","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000343162","article-title":"Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia","volume":"58","year":"2012","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170522105039_CIU398C45","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/AAC.05664-11","article-title":"Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow-fiber infection model","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T22:58:58Z","timestamp":1716764338000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/ciu398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,27]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,27]]},"published-print":{"date-parts":[[2014,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciu398","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,27]]}}}